Postdoc Position in Cell-Targeted Oligonucleotide Delivery in Congenital Muscular Dystrophies

Biography

Dr Haiyan Zhou is an Associate Professor at University College London. Her research focuses on preclinical development of RNA-targeted novel therapies and translational biomedical research in rare genetic disorders.

Dr Zhou is the deputy lead of the Novel Therapy Theme in the NIHR Biomedical Research Centre at UCL Great Ormond Street Hospital and Institute of Child Health. She is also the director of the MSc Personalized Medicine and Novel Therapies Programme at UCL.

Dr Haiyan Zhou is member of World Muscle Society, Oligonucleotide Therapeutic Society and American Society of Gene and Cell Therapy. She is also the UK representative and management committee member of the European Cooperation in Science and Technology (e-COST) on ‘Delivery ofAntisense RNA Therapeutics’. Dr Zhou is the 2021 Harrington UK Rare Disease Scholar.

Dr Zhou holds a medical degree in clinical medicine and PhD award from Peking Union Medical College.

We are recruiting! An exciting 3-year postdoc position in our lab working on cell-targeted oligonucleotide delivery in congenital muscular dystrophies, funded by Muscular Dystrophy UK.